Trial Profile
A Phase I Study to Evaluate the Safety and Pharmacokinetics of RadProtect in Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Amifostine (Primary)
- Indications Acute radiation syndrome
- Focus Adverse reactions
- Sponsors Original BioMedicals
- 04 Nov 2015 New trial record